Medicine & Life Sciences
Acquired Immunodeficiency Syndrome
11%
Africa South of the Sahara
7%
Anti-Bacterial Agents
6%
Azithromycin
20%
Bacterial Vaginosis
16%
Belgium
83%
Biomarkers
7%
Blastomyces
15%
Blastomycosis
5%
Ceftriaxone
6%
Cephalosporins
11%
Chlamydia
29%
Chlamydia trachomatis
11%
Chrysosporium
17%
Cohort Studies
11%
Confidence Intervals
6%
Cross-Sectional Studies
9%
Cryptococcus neoformans
9%
Culture Techniques
5%
Eastern Africa
5%
Ecosystem
7%
Epidemiology
6%
Ethiopia
9%
Ethnic Groups
8%
Feathers
5%
Fenofibrate
5%
Fluoroquinolones
13%
Fungal Spores
5%
Fungi
13%
Genome
6%
Genotype
6%
Globus Pallidus
10%
Gonorrhea
51%
Greenland
5%
Guidelines
8%
Heterosexuality
12%
HIV
100%
HIV Infections
15%
Human Herpesvirus 2
12%
Immune Reconstitution Inflammatory Syndrome
5%
Incidence
11%
Infection
24%
Kenya
21%
Linear Models
9%
Logistic Models
5%
Lymphogranuloma Venereum
6%
Macrolides
36%
Male Circumcision
5%
Mass Spectrometry
6%
Microbial Drug Resistance
12%
Microbial Sensitivity Tests
5%
Microbiota
6%
Molecular Typing
5%
Mouthwashes
11%
Mutation
6%
Mycoplasma genitalium
12%
Mycoses
18%
Neisseria
10%
Neisseria gonorrhoeae
44%
Neurosyphilis
5%
Observational Studies
8%
Odds Ratio
5%
Onygenales
14%
Polymerase Chain Reaction
6%
Population
23%
Post-Exposure Prophylaxis
5%
Pravastatin
5%
Primary Health Care
6%
Prospective Studies
5%
Proteins
5%
Proteome
9%
Reagins
8%
Ribosomal Proteins
5%
Risk-Taking
17%
SARS Virus
7%
Sexual Behavior
23%
Sexual Partners
25%
Sexually Transmitted Diseases
72%
Skin
6%
South Africa
64%
Southern Africa
6%
Streptococcus pneumoniae
6%
Syphilis
85%
Therapeutics
10%
Treponema pallidum
43%
Trichomonas vaginalis
5%
Uganda
9%
Urease
9%
Urine
6%
Virulence Factors
5%